PD-L1 Expressions in Non-small Cell Lung Cancer and its Correlation with Imaging Findings

被引：0
|
作者：
Shigeta, N. [1 ]
Adachi, H. [1 ]
Ito, H. [1 ]
Isaka, T. [1 ]
Murakami, K. [1 ]
Miura, J. [1 ]
Kikunishi, N. [1 ]
Saito, H. [1 ]
Yokose, T. [1 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
non-small cell lung cancer; PD-L1; imaging features;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.02-03
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [41] Anti-PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy
    Valecha, Gautam Kishore
    Vennepureddy, Adarsh
    Ibrahim, Uroosa
    Safa, Firas
    Samra, Bachar
    Atallah, Jean Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (01) : 47 - 59
  • [42] Exosomal PD-L1 in non-small cell lung Cancer: Implications for immune evasion and resistance to immunotherapy
    Tarin, Mojtaba
    Oryani, Mahsa Akbari
    Javid, Hossein
    Karimi-Shahri, Mehdi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 155
  • [43] Globo H expression is associated with driver mutations and PD-L1 expressions in stage I non-small cell lung cancer
    Yang, Ching-Yao
    Lin, Mong-Wei
    Chang, Yih-Leong
    Wu, Chen-Tu
    CANCER BIOMARKERS, 2018, 21 (01) : 211 - 220
  • [44] PD-1 and PD-L1 Inhibitors: Activity as Single Agents and Potential Biomarkers in Non-Small Cell Lung Cancer
    Goldberg, Sarah B.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (09) : 10 - 13
  • [45] PD-L1 Expression in Adenosquamous Lung Carcinoma and the Comparison with the Other Common Variants of Non-Small Cell Lung Cancer
    Shi, Xiaohua
    Wu, Shafei
    Sun, Jian
    Liu, Yuanyuan
    Zeng, Xuan
    Liang, Zhiyong
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S989 - S989
  • [46] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
    Munari, Enrico
    Zamboni, Giuseppe
    Marconi, Marcella
    Sommaggio, Marco
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Moretta, Francesca
    Mingari, Maria Cristina
    Salgarello, Matteo
    Terzi, Alberto
    Picece, Vincenzo
    Pomari, Carlo
    Lunardi, Gianluigi
    Cavazza, Alberto
    Rossi, Giulio
    Moretta, Lorenzo
    Bogina, Giuseppe
    ONCOTARGET, 2017, 8 (52): : 90123 - 90131
  • [47] Correlation between immunotherapy biomarker PD-L1 expression and genetic alteration in patients with non-small cell lung cancer
    Chen, Hefeng
    Ge, Mengxi
    Zhang, Fuchuang
    Xing, Yishi
    Yu, Shicheng
    Chen, Chunzhu
    Zhang, Hougang
    Wang, Xiaoyong
    Gao, Xing
    Chen, Fangtao
    Chen, Peilin
    Zhang, Dadong
    Zhan, Qiong
    Zhu, Youcai
    GENOMICS, 2023, 115 (04)
  • [48] Correlation Between PD-L1 Expression and Expression of CDK4 and SPOP in Non-Small Cell Lung Cancer
    Inoue, M.
    Yoshida, J.
    Oka, S.
    Honda, Y.
    Yasuda, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S924 - S924
  • [49] Polymorphisms of the PD-L1 gene 3′-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer
    Ohhara, Yoshihito
    Tomaru, Utano
    Kinoshita, Ichiro
    Hatanaka, Kanako C.
    Noguchi, Takuro
    Hatanaka, Yutaka
    Amono, Toraji
    Matsuno, Yoshihiro
    Dosaka-Akita, Hirotoshi
    GENES CHROMOSOMES & CANCER, 2024, 63 (01)
  • [50] Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer
    Koh, Young Wha
    Han, Jae-Ho
    Haam, Seokjin
    PATHOLOGY, 2021, 53 (02) : 239 - 246
12345